GSK
Pharma

GSK's Jemperli snags FDA nod in rectal cancer after data buzz

The accelerated approval makes Jemperli the first immunotherapy for patients with stage 2 and 3 locally advanced rectal cancer that is MSI-H/dMMR.
Angus Liu Oct 19, 2026 1:24pm
Podcast
The Next Chapter for AI in Clinical Trials

The Next Chapter for AI in Clinical Trials

Brought to you by Saama
road closed construction sign

EyePoint reeling for stability after another AMD ph. 3 flop

Oct 19, 2026 11:32am
Why Are 53 of Phase 2 and 3 Trials Delayed A Redesign Is Overdue

Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue

Brought to you by Bain & Company
euro

Roche pauses future Germany investments

Oct 19, 2026 10:25am
High magnification micrograph of diffuse proliferative lupus nephritis

Novartis presses pause on Fabhalta lupus nephritis trial

Oct 19, 2026 10:13am
More News

Lilly's Omvoh to seek pediatric UC approval

Oct 19, 2026 8:57am

Viola Davis opens up about shingles experience in GSK campaign

Oct 16, 2026 6:04pm

JEC Democrats scrutinize Trump's soaring pharma holdings

Oct 16, 2026 2:50pm

The Oral GLP-1 Tracker: Lilly, Novo undergo minor fluctuations

Oct 16, 2026 2:25pm